Top Markets
Coin of the day
Homology Medicines, Inc. Homology Medicines, Inc.

Homology Medicines, Inc.

FIXX
주식 순위 #39911
Homology Medicines, Inc. is a biotechnology firm dedicated to genetic... Homology Medicines, Inc. is a biotechnology firm dedicated to genetic therapeutics, striving to enhance the well-being of patients battling rare inherited disorders. The company leverages its unique platform, which employs adeno-associated virus vectors (AAVHSCs) originating from human hematopoietic stem cells, to introduce genetic treatments directly into the body. This approach facilitates either gene therapy or nuclease-free gene editing solutions for a range of genetic ailments. Crucially, Homology's diverse collection of AAVHSCs enables the precise targeting of multiple disease-affected tissues—such as the liver, central and peripheral nervous systems, bone marrow, heart, skeletal muscles, and eyes—all from a single administration. The leading candidate in their pipeline, HMI-102, is a gene therapy undergoing the Phase 2 pheNIX clinical trial, intended for adult patients with phenylketonuria (PKU). Beyond this, their development portfolio includes HMI-103 for pediatric PKU, HMI-202 targeting metachromatic leukodystrophy, HMI-203 for mucopolysaccharidosis type II, and HMI-104 designed to address paroxysmal nocturnal hemoglobinuria. Established in 2015, Homology Medicines, Inc. maintains its corporate headquarters in Bedford, Massachusetts.
주가
$0.9347
마지막 동기화: 2024-03-25
시가총액
$300.42K
변동 (1일)
0.75%
변동 (1년)
0.00%
국가
US
거래 Homology Medicines, Inc. (FIXX)

카테고리

Homology Medicines, Inc. (FIXX)의 주가 이력
최고 종가: $0.90 (2024-03-01 기준)

최저 종가: $18.68 (2018-03-01 기준)
Homology Medicines, Inc.의 주가 이력 (2018 ~ 2026)
연간 주가 성과
연도 성과
2024 62.24%
2023 -59.20%
2022 -67.95%
2021 -61.63%
2020 -44.79%
2019 -12.55%
2018 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.09%
KR
$259.89 14.81%
BE